EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›NSLR

NSLR

SURO CAPITAL CORP.

Next earnings ≈ Aug 5, 2026 · est. from filing cadence

Hold
$11.79
▲ —
$11.79▼ -14.32%
over 1Y
L $11.79H $14.91
Today—
1W-0.1%
1M-20.9%
3M-14.3%
YTD-14.3%
1Y-14.3%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
A
Valuation
Undervalued
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••

That 6.6 P/E is a mirage — this venture BDC trades ~46% over NAV on lumpy Level-3 marks.

Price / diluted EPS (P/E) 6.6 · FY2025 EPS $1.78

The read

Middling fundamentals offset by an attractive price (~474% below fair value) — worth a look on the value angle.

SuRo is not an operating company but an internally-managed BDC/RIC whose 'earnings' are overwhelmingly unrealized gains and losses on a portfolio the MD&A describes as growth-stage, venture-capital-backed private companies, and whose 10-K states 'the majority of the Company's investments are Level 3 investments and are subject to a high degree of judgment and uncertainty in determining fair value.' That single fact reframes everything: the headline 6.6x P/E on $1.78 diluted EPS looks cheap, but it is priced off a mark-to-market print, not durable income. The net-income record proves the point — +$147M (FY21), -$132M (FY22), +$5M (FY23), -$38M (FY24), +$49M (FY25). Two of the last four years were large losses. You cannot capitalize that stream at a stable multiple.

The better anchor for a BDC is NAV. Stockholders' equity of $205M over 25.4M shares implies roughly $8.07 of net asset value per share, yet the stock trades at $11.79 — a ~46% premium to stated NAV. That is unusual and rich for a venture BDC, where most peers trade at or below NAV precisely because the underlying private marks are illiquid and uncertain. The premium is the crux of the call: it means the market is already paying up for a strong year, leaving little margin of safety if the next quarterly revaluation moves against them (the MD&A explicitly flags that an economic downturn or a contraction in credit/equity markets could impair portfolio companies and force losses).

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue—————
Gross profit—————
Operating income—————
Net income$147M-$132M$5.07M-$38.1M$48.8M
Diluted EPS$5.52-$4.40$0.19-$1.60$1.78
Net margin—————

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)0.03
Earnings yield15.9%
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash—

Capital returns

Buyback yield3.1%
Dividend yield (est.)3.9%
Shareholder yield6.9%
Shares Δ YoY+7.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Charter / bylaws change2026-06-26

    Amended charter/bylaws (Item 5.03) — governance housekeeping, no P&L impact

  2. 8-K Shareholder vote2026-06-12

    Annual-meeting vote results disclosed; board slate & proposals ratified

  3. 10-Q Quarterly report2026-05-06

    Q1 2026 report; ~$205M equity base after record 2025

  4. 8-K Earnings results2026-05-05

    Announced Q1 2026 results and NAV-per-share update

  5. DEF 14A Proxy statement2026-04-29

    Definitive/additional proxy materials for 2026 annual meeting

  6. DEF 14A Proxy statement2026-04-29

    Definitive/additional proxy materials for 2026 annual meeting

  7. 8-K Earnings results2026-04-07

    Interim portfolio/NAV results plus Item 8.01 other-event disclosure

  8. 10-K Annual report2026-03-11

    FY2025: net income $48.8M, EPS $1.78, ROE 23.8% — record year

  9. 8-K Earnings results2026-03-10

    Announced record FY2025 results — ~$48.8M net income

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-262026-06-26open ↗4Period ending 2026-06-232026-06-25open ↗144Filing2026-06-23open ↗4Period ending 2026-06-122026-06-16open ↗4Period ending 2026-06-122026-06-16open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗8-KPeriod ending 2026-06-122026-06-12open ↗10-QPeriod ending 2026-03-312026-05-06open ↗

Quality score

A
ValueGrowthProfitHealthMom.
ValueA+
GrowthA+
ProfitabilityA
Financial healthA-
Momentum—
  • ✓Profitable (positive net income)
  • ✓Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$67.64

Undervalued +474% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.78 × (8.5 + 1.5 × 22.0% growth) × 1.10 quality = 38.0× multiple. An estimate, not a price target.

0.0052-week0.00
Revenue
—
Net margin
—
ROE
23.8%
P/E
6.6

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Net income$48.8M+228.0%
Diluted EPS$1.78+211.2%
Total assets$276M+19.2%
Total liabilities$70.7M-4.5%
Stockholders' equity$205M+30.3%
L/E: 0.34x

Frequently asked

Is SURO CAPITAL CORP. (NSLR) a buy?
NSLR currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. That 6.6 P/E is a mirage — this venture BDC trades ~46% over NAV on lumpy Level-3 marks.
What is NSLR's fair value?
A Modified-Graham model based on NSLR's SEC fundamentals estimates a fair value of about $67.64. It is an estimate from reported earnings, not a price target.
Is NSLR overvalued or undervalued?
Against a Modified-Graham fair-value estimate, NSLR currently appears undervalued relative to its SEC-grounded earnings power.
What is SURO CAPITAL CORP.'s quality score?
NSLR scores 89.11764705882352/100 (grade A) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001509470, latest 10-Q filed 2026-05-06) · EODHD · Proprietary analysis · as of 7/4/2026, 3:23:08 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 1 sale

2026-06-23
LOTT RONALD M.
Director
Sell500.00 @ $12.35$6.17K
2026-06-15
Green Allison
See Remarks
Tax41.8K @ $13.56$567K
2026-06-15
Klein Mark D
Chairman, CEO and President
Tax293K @ $13.56$3.98M
2026-06-12
Green Allison
See Remarks
Award60.0K
2026-06-12
Klein Mark D
Chairman, CEO and President
Award350K
2026-06-10
Westley Lisa
Director
Award3.54K
2026-06-10
Mazur Marc
Director
Award3.54K
2026-06-10
Szuch Richard C.
Director
Award3.54K
2026-06-10
LOTT RONALD M.
Director
Award3.54K
2026-06-10
Potter Leonard
Director
Award3.54K

Earnings history

beat/miss · move
2026-05-05——8-K ↗
2026-04-07——8-K ↗
2026-03-10——8-K ↗
2026-01-12——8-K ↗
2025-11-04——8-K ↗
2025-10-09——8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Vs tracked universe

compare →

1195 tracked peers · median

EDGAR Score89 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity23.8% vs 12.0%
P/E6.6 vs 26.2